Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Joshua Ziel, Ph.D., Appointed As Chief Executive Officer of Bryn Pharma, Llc

PRIVATEOct 24, 2024•over 1 year ago

Position

Chief Executive Officer

Company

Bryn Pharma

Joshua Ziel
LebanonManufacturingHealthcareHealth Care

Description

Bryn Pharma, LLC has announced the appointment of Joshua Ziel, Ph.D., as the Chief Executive Officer and member of the Board of Directors. This appointment comes as Sandy Loreaux, former CEO, steps down for family-related reasons but will continue to serve on the Board of Directors to guide company strategy.

Company Information

Company

Bryn Pharma

Location

26 STILL HOLLOW RD

Lebanon, Pennsylvania, United States

About

Bryn Pharma is a privately held pharmaceutical company based in North Carolina, focused on developing and commercializing innovative allergy treatments for managing anaphylaxis. Its mission is to empower patients with a life-saving device that fits comfortably in a pocket and is easy to use during an anaphylactic attack. The company’s intranasal delivery system offers a needle-free, portable, and affordable alternative to epinephrine auto-injectors.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Bryn Pharma's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.